Suchergebnis | Hamburg Open Science

Facetten

35 Einträge gefunden

Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity Indexes
2019 - Forschungsinformationssystem des UKE
Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification
2018 - Forschungsinformationssystem des UKE
The diagnosis of benign prostatic obstruction: Development of a clinical nomogram
2016 - Forschungsinformationssystem des UKE
Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
2012 - Forschungsinformationssystem des UKE
Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
2009 - Forschungsinformationssystem des UKE
Prediction of sexual function after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
2008 - Forschungsinformationssystem des UKE
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.
2008 - Forschungsinformationssystem des UKE
Is node-positive prostate cancer always a systemic disease?
2008 - Forschungsinformationssystem des UKE
Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values.
1. Chun, Felix
2. Briganti, Alberto
2008 - Forschungsinformationssystem des UKE
Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
2008 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
2007 - Forschungsinformationssystem des UKE
Prostate volume and adverse prostate cancer features: fact not artifact.
2007 - Forschungsinformationssystem des UKE
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
2007 - Forschungsinformationssystem des UKE
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity Indexes

Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification

The diagnosis of benign prostatic obstruction: Development of a clinical nomogram

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.

Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.

Prediction of sexual function after radical prostatectomy.

Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.

Is node-positive prostate cancer always a systemic disease?

Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values.

Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.

Prostate volume and adverse prostate cancer features: fact not artifact.

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.

Development and external validation of an extended 10-core biopsy nomogram.

Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.